Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Pre-clinically EO2401 generates strong immune responses and cross-reactive CD8 cells recognizing the Tumor-associated antigens (TAA) (1)
It is a randomized clinical phase I/II treatment trial studying EO2401 vs EO2401 + Nivolumab vs Nivolumab in patients with histologically confirmed (at primary diagnosis) unresectable locally advanced or metastatic adrenocortical carcinoma or unresectable metastatic [pheochromocytoma](brain://WllGCU1X…